...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Bear
2
Apr 16, 2018 08:56AM
2
Apr 16, 2018 01:24PM

Apr 16, 2018 04:24PM
4
Apr 16, 2018 08:07PM

fouremm - This time around the company has been very clear that additional trials would depend on money. Have you seen enough money raised and closed to do that yet?

tada

1
Apr 17, 2018 01:35PM
1
Apr 17, 2018 03:32PM

Apr 17, 2018 05:13PM
Share
New Message
Please login to post a reply